Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Innate Pharma S.A. ADR (NQ: IPHA ) 1.845 UNCHANGED Streaming Delayed Price Updated: 1:28 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Innate Pharma S.A. ADR < Previous 1 2 3 4 5 6 7 8 Next > Innate Pharma Files Its 2021 Universal Registration Document (Document d’enregistrement universel) and 2021 Annual Report on Form 20-F April 05, 2022 From Innate Pharma SA Via Business Wire Earnings Scheduled For March 24, 2022 March 24, 2022 Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to... Via Benzinga Innate Pharma Reports Full Year 2021 Financial Results and Business Update March 24, 2022 From Innate Pharma SA Via Business Wire Innate Pharma FY 2021 Earnings Conference Call On March 24, 2022 At 09:00 AM ET March 22, 2022 Innate Pharma (NASDAQ:IPHA) will host a conference call at 09:00 AM ET on March 24, 2022, to discuss FY 2021 earnings results. How to Attend Innate Pharma (IPHA) Conference Call... Via Benzinga Innate Pharma Announces Conference Call and Webcast for Full Year 2021 Financial Results March 17, 2022 From Innate Pharma SA Via Business Wire 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 10, 2022 Gainers Innate Pharma (NASDAQ:IPHA) stock increased by 13.7% to $3.32 during Thursday's pre-market session. The market value of their outstanding shares is at $264.6... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session March 07, 2022 Gainers Via Benzinga Number of Shares and Voting Rights of Innate Pharma as of February 1, 2022 February 15, 2022 From Innate Pharma SA Via Business Wire Innate Pharma to Participate in Upcoming Investor Conferences February 04, 2022 From Innate Pharma SA Via Business Wire 20 Stocks Moving in Tuesday's Pre-Market Session January 25, 2022 Gainers Aptorum Group Limited (NASDAQ: APM) shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation... Via Benzinga Number of Shares and Voting Rights of Innate Pharma as of January 1, 2022 January 24, 2022 From Innate Pharma S.A. Via Business Wire The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets January 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,... Via Benzinga Innate Pharma Obtains €28.7m in Non-Dilutive Financing in the Form of State Guaranteed Loans January 05, 2022 From Innate Pharma SA Via Business Wire Innate Pharma to Participate in Upcoming Investor Conferences January 04, 2022 From Innate Pharma SA Via Business Wire 18 Stocks Moving in Monday's Pre-Market Session January 03, 2022 Gainers Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 41.6% to $3.13 in pre-market trading after gaining around 8% on Friday. Armstrong Flooring, Inc. (NYSE: AFI... Via Benzinga Innate Pharma: First Patient Dosed in IPH6101/SAR443579 Phase 1/2 Clinical Trial in Various Blood Cancers December 16, 2021 From Innate Pharma SA Via Business Wire Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity December 09, 2021 Innate Pharma SA's (NASDAQ: IPHA) data from the Phase 2 expansion cohort (cohort 3) evaluating the monalizumab triplet combination shows preliminary activity and an... Via Benzinga The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO December 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug... Via Benzinga Exposures COVID-19 Product Safety Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress December 09, 2021 From Innate Pharma S.A. Via Business Wire The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More December 06, 2021 The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative... Via Benzinga Exposures Product Safety Innate Pharma to Present Monalizumab Data at ESMO Immuno-Oncology 2021 Congress December 02, 2021 From Innate Pharma SA Via Business Wire Innate Pharma to Participate in the Evercore ISI 4th Annual HealthConX Virtual Conference November 24, 2021 From Innate Pharma SA Via Business Wire Innate Pharma Third Quarter 2021 Report November 16, 2021 From Innate Pharma S.A. Via Business Wire Innate Pharma Announces Conference Call and Webcast for Q3 2021 Business Update November 09, 2021 From Innate Pharma SA Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session November 01, 2021 Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's pre-market session. The company's market cap stands at $27.1... Via Benzinga Innate Pharma 2022 Financial Calendar October 26, 2021 From Innate Pharma SA Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session October 25, 2021 Gainers Medpace Hldgs (NASDAQ:MEDP) shar... Via Benzinga Number of Shares and Voting Rights of Innate Pharma as of October 1, 2021 October 15, 2021 From Innate Pharma Via Business Wire 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 30, 2021 Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The company's market cap stands at $1.4 billion.... Via Benzinga 18 Stocks Moving in Thursday's Pre-Market Session September 30, 2021 Gainers Superior Drilling Products, Inc. (NYSE: SDPI) rose 58.7% to $1.73 in pre-market trading after jumping over 23% on Wednesday. The company, last month, reported Q2... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
